Commensal-Related Changes in the Epidermal Barrier Function Lead to Alterations in the Benzo[ a ]Pyrene Metabolite Profile and Its Distribution in 3D Skin

• Published in: mBio Vol. 12; no. 5; p. e0122321
• Main Authors: Lemoine, Lisa, Bayrambey, Dilan, Roloff, Alexander, Hutzler, Christoph, Luch, Andreas, Tralau, Tewes
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 26.10.2021
• Subjects: Benzo(a)pyrene - metabolism; Benzo(a)pyrene - pharmacology; Cell Culture Techniques; DNA Damage - genetics; DNA Repair - genetics; Host-Microbial Interactions; Humans; In Vitro Techniques; Microbiota - drug effects; Microbiota - genetics; Microbiota - physiology; Research Article; Skin - drug effects; Skin - metabolism; Skin - microbiology; Skin Physiological Phenomena - drug effects; Symbiosis - drug effects; Symbiosis - physiology; GC-MS; skin barrier; benzo[a]pyrene; coculture; skin model; commensals; epidermal barrier; metabolites; BPDE DNA adducts
• ISSN: 2150-7511; 2150-7511
• DOI: 10.1128/mBio.01223-21

Exposure to xenobiotics has repeatedly been associated with adverse health effects. While the majority of reported cases relate to direct substance effects, there is increasing evidence that microbiome-dependent metabolism of xenobiotic substances likewise has direct adverse effects on the host. Polycyclic aromatic hydrocarbons (PAH) such as benzo[ a ]pyrene (B[ a ]P) are among the most abundant environmental pollutants, resulting in continuous exposure of human skin and its microbiota. However, effects of the latter on B[ a ]P toxicity, absorption, metabolism, and distribution in humans remain unclear. Here, we demonstrate that the skin microbiota does metabolize B[ a ]P on and in human skin in situ , using a recently developed commensal skin model. In this model, microbial metabolism leads to high concentrations of known microbial B[ a ]P metabolites on the surface as well as in the epidermal layers. In contrast to what was observed for uncolonized skin, B[ a ]P and its metabolites were subject to altered rates of skin penetration and diffusion, resulting in up to 58% reduction of metabolites recovered from basal culture medium. The results indicate the reason for this altered behavior to be a microbially induced strengthening of the epidermal barrier. Concomitantly, colonized models showed decreased formation and penetration of the ultimate carcinogen B[ a ]P-7,8-dihydrodiol-9,10-epoxide (BPDE), leading, in consequence, to fewer BPDE-DNA adducts being formed. Befittingly, transcript and expression levels of key proteins for repairing environmentally induced DNA damage such as xeroderma pigmentosum complementation group C (XPC) were also found to be reduced in the commensal models, as was expression of B[ a ]P-associated cytochrome P450-dependent monooxygenases (CYPs). The results show that the microbiome can have significant effects on the toxicology of external chemical impacts. The respective effects rely on a complex interplay between microbial and host metabolism and microbe-host interactions, all of which cannot be adequately assessed using single-system studies. IMPORTANCE Exposure to xenobiotics has repeatedly been associated with adverse health effects. While the majority of reported cases relate to direct substance effects, there is increasing evidence that microbiome-dependent metabolism of xenobiotic substances likewise has direct adverse effects on the host. This can be due to microbial biotransformation of compounds, interaction between the microbiota and the host’s endogenous detoxification enzymes, or altered xenobiotic bioavailability. However, there are hardly any studies addressing the complex interplay of such interactions in situ and less so in human test systems. Using a recently developed microbially competent three-dimensional (3D) skin model, we show here for the first time how commensal influence on skin physiology and gene transcription paradoxically modulates PAH toxicity.